Prevention
-
BRCA: Who Should Be Tested?
Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
-
Avoiding Unnecessary Lymph Node Biopsy
A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.
by Cheryl Platzman Weinstock
-
From the Editor-in-Chief
Clonal Hematopoiesis: You Are Not the Same Person You Used to BeDNA sequencing of blood cells may provide clues for how cancer and other illnesses develop.
by William G. Nelson, MD, PhD
-
Forward Look
Learning How to Prevent Multiple MyelomaIrene Ghobrial on studying cancer precursors.
by Sue Rochman
-
Forward Look
Let the Buyer Be AwareAt-home genetic tests offer limited information on cancer risk.
by Sharon Tregaskis
-
Forward Look
Teen Use of Tobacco Products Spirals UpwardE-cigarettes are upending decades of smoke-free successes.
by Nancy Averett
-
Healthy Habits
Where There’s SmokeWhat to know before firing up the grill during barbecue season.
by Bradley Jones
-
Healthy Habits
Overlooking ObesityPublic awareness of the link between obesity and cancer risk is poor.
by Jane C. Hu
-
Lung Cancer and Stigma
Clinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event
Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin